IK Investment Partners (“IK”) announced that the IK VIII Fund has reached an agreement to acquire Klingel medical metal GmbH (“KLINGEL” or “the Company”), a leading manufacturer of high-precision and complex metal components mainly for a range of medical technology applications, from Halder.
KLINGEL was established in 1986 and has become a leading independent contract manufacturer of high-precision, hard-to-machine parts made from titanium and high-grade types of stainless steel. The Company operates a vertically integrated business model with in-house capabilities spanning the entire production value chain from design to manufacture to final packaging with a strategic focus on medical technology.
KLINGEL represents the IK VIII Fund’s second mid cap acquisition in the past month, and the 11th acquisition announced by the Fund. Financial terms of the transaction are not disclosed.
Parties involved in this transaction:
IK Investment Partners: Anders Petersson, Mirko Jablonsky, Alexander Dokters, Adrian Tanski, Daniel-Vito Günther
Buyer financial adviser: Quarton International (Lars Veit, Rolf Holtmann)
Buyer strategic due diligence: Alvarez & Marsal (Georg Hochleitner)
Buyer financial due diligence: Ebner Stolz (Claus Bähre)
Buyer legal adviser: Renzenbrink & Partner (Ulf Renzenbrink)
Halder: Michael Wahl, Christian Muschalik
Seller financial adviser: William Blair (Philipp Mohr, Moritz Rottwinkel)
Seller legal adviser: Graf von Westfalen (Lutz Zimmer, Ernst Lindl)
